{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T05:26:05Z","timestamp":1770528365411,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2504,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.bbmt.2008.03.006","type":"journal-article","created":{"date-parts":[[2008,5,18]],"date-time":"2008-05-18T04:08:08Z","timestamp":1211083688000},"page":"651-657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for De Novo Acute Myelogenous Leukemia with a Conditioning Regimen of Total Body Irradiation and Granulocyte Colony-Stimulating Factor-Combined High-Dose Cytarabine"],"prefix":"10.1016","volume":"14","author":[{"given":"Takehiko","family":"Mori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Aisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Shigematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonaru","family":"Yajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifumi","family":"Hibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2008.03.006_bib1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1182\/blood.V81.4.1094.1094","article-title":"Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?","volume":"81","author":"Ringd\u00e9n","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.006_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJM199501263320403","volume":"332","author":"Zittoun","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2008.03.006_bib3","first-page":"1687","article-title":"HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission","volume":"10","author":"Gale","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2008.03.006_bib4","first-page":"741","article-title":"Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine","volume":"18","author":"Mehta","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.03.006_bib5","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1046\/j.1365-2141.2002.03973.x","article-title":"Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission","volume":"119","author":"Litzow","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2008.03.006_bib6","first-page":"924","article-title":"Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT)","volume":"8","author":"Frassoni","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2008.03.006_bib7","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood.V78.3.838.838","article-title":"Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2","volume":"78","author":"Copelan","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.006_bib8","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/sj.bmt.1702690","article-title":"Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle (SFGM)","volume":"26","author":"Michallet","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.03.006_bib9","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1182\/blood.V80.4.1090.1090","article-title":"Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy","volume":"80","author":"Biggs","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.006_bib10","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1200\/JCO.1992.10.11.1723","article-title":"Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia","volume":"10","author":"Clift","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.03.006_bib11","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.bbmt.2003.08.004","article-title":"A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome","volume":"9","author":"Fung","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.03.006_bib12","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood.V73.5.1272.bloodjournal7351272","article-title":"Growth factors influence the sensitivity of leukemic stem cells to cytosine arabinoside in culture","volume":"73","author":"Miyauchi","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.006_bib13","first-page":"17","article-title":"Comparative effects of G-CSF, GM-CSF, and IL-3 on cytosine arabinoside- and daunorubicin-mediated cytotoxicity of acute myeloid leukemia cells and normal myeloid progenitors","volume":"56","author":"Waga","year":"1992","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2008.03.006_bib14","first-page":"239","article-title":"Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia","volume":"13","author":"Takahashi","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.03.006_bib15","first-page":"301","article-title":"Multidrug resistance expression and proliferative studies in poor risk acute myeloid leukemia treated with the FLAG (G-CSF plus fludarabine and Ara-C) regimen","volume":"1","author":"Tafuri","year":"1995","journal-title":"Cytokine Mol Ther"},{"key":"10.1016\/j.bbmt.2008.03.006_bib16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1200\/JCO.1994.12.4.671","volume":"12","author":"Estey","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.03.006_bib17","first-page":"238","volume":"71","author":"Saito","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2008.03.006_bib18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJMoa025406","article-title":"Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia","volume":"349","author":"Lowenberg","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2008.03.006_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood-2004-09-3728","article-title":"Use of glycosylated recombinant human G-CSF (lenograstim) during and\/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study","volume":"106","author":"Amadori","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.006_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2141.1999.01205.x","article-title":"Treatment of advanced myelodysplastic syndrome with a regimen including recombinant human granulocyte colony-stimulating factor preceding allogeneic bone marrow transplantation","volume":"104","author":"Okamoto","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2008.03.006_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/(SICI)1096-8652(199804)57:4<303::AID-AJH6>3.0.CO;2-Y","article-title":"Recombinant human granulocyte colony-stimulating factor (G-CSF) combined conditioning regimen for allogeneic bone marrow transplantation (BMT) in standard-risk myeloid leukemia","volume":"57","author":"Takahashi","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2008.03.006_bib22","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1182\/blood-2004-03-1001","article-title":"Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies","volume":"104","author":"Takahashi","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.006_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.bmt.1705578","article-title":"Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience","volume":"39","author":"Mori","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.03.006_bib24","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1182\/blood-2004-02-0545","article-title":"Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities","volume":"104","author":"Sorror","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.006_bib25","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1182\/blood-2004-03-0804","article-title":"Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors","volume":"104","author":"Diaconescu","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.006_bib26","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.006_bib27","first-page":"825","article-title":"Consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.03.006_bib28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2008.03.006_bib29","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1200\/JCO.1988.6.4.576","article-title":"High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia","volume":"6","author":"Riddell","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.03.006_bib30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/mpo.2950250304","article-title":"Fractionated toral-body irradiation preceding high-dose cytosine arabinoside as a preparative regimen for bone marrow transplantation in children with acute leukemia","volume":"25","author":"Kamani","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.bbmt.2008.03.006_bib31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1532\/IJH97.05134","article-title":"Current status of hematopoietic cell transplantation for adult patients with hematologic diseases and solid tumors in Japan","volume":"83","author":"Imamura","year":"2006","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2008.03.006_bib32","first-page":"2931","volume":"90","author":"Ferrant","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.006_bib33","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1182\/blood-2002-12-3714","article-title":"Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC\/GIMEMAAML-10 trial","volume":"102","author":"Suciu","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.006_bib34","first-page":"203","article-title":"Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission","volume":"16","author":"Gale","year":"1995","journal-title":"Bone Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879108001158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879108001158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:31:50Z","timestamp":1761057110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879108001158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S1083879108001158"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2008.03.006","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for De Novo Acute Myelogenous Leukemia with a Conditioning Regimen of Total Body Irradiation and Granulocyte Colony-Stimulating Factor-Combined High-Dose Cytarabine","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2008.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}